Increased angiogenesis in the bone marrow of HIV-positive patients with myelodysplasia

Pathology

Volumn 35, Issue 4, 2003, Pages 330-335

  Patsouris, Efstratios ^a   Korkolopoulou, Penelope ^a   Androulaki, Athina ^a   Douzinas, Emmanuel ^a   Kosmopoulou, Olga ^a   Kordossis, Theodore ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Angiogenesis; HIV infection; Myelodysplastic syndrome; Primary myelodysplastic syndrome

Indexed keywords

ADULT; ANGIOGENESIS; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CELL VIABILITY; CLINICAL ARTICLE; FEMALE; HEMATOPOIETIC CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE ACTIVATION; MALE; MICROVASCULATURE; MYELODYSPLASIA; NEOVASCULARIZATION (PATHOLOGY); PATHOGENESIS; QUANTITATIVE ANALYSIS; SOLID TUMOR; VASCULAR ENDOTHELIUM;

EID: 0042333463     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/0031302031000150506     Document Type: Article

References (55)

1. Aguayo A, Kantargian H, Talpaz M. Increased angiogenesis in chronic myeloid leukemia and myelodysplastic syndromes (abstract). Blood 1998; 92 (Suppl): 607.
2. Folkman J. Angiogenesis in cancer, vascular rheumatoid and other diseases. Nat Med 1995; 1: 27-31.
3. Irnela-Arispe ML, Dvorak HF. Angiogenesis: a dynamic balance of stimulators and inhibitors. Thromb Haemost 1997; 78: 672-7.
4. Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 1995; 146: 1029-39.
5. Padro T, Ruiz S, Bieker R, et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000; 95: 2637-44.
6. Weidner N, Semple JP, Welch WR, et al. Tumour angiogenesis and metastasis - correlation in invasive breast carcinoma. New Engl J Med 1991; 324: 1.
7. Gasparini G, Weidner N, Matula S, et al. Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous cell carcinoma. Int J Cancer 1993; 55: 738.
8. Srivastava A, Laidler P, Davies RP, et al. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma: a quantitative histologic study. Am J Pathol 1988; 133: 419-23.
9. Bochner BH, Cote RJ, Weidner N, et al. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 1995; 87: 1603-12.
10. Brouver MK, Deering RE, Brown M, et al. Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer 1994; 73: 678-87.
11. Vamaraki K, Abe S, Tagekawa H, et al. Tumor angiogenesis in human lung adenocarcinoma. Cancer 1994; 74: 2245-50.
12. Schnitt SJ. The real value of angiogenesis research in breast cancer. Adv Anat Pathol 1997; 4: 23-7.
13. Weidner N, Carroll PR, Flay J, et al. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993; 143: 401.
14. Ellis LM, Fidler IJ. Angiogenesis and breast cancer metastasis. Lancet 1995; 346: 388.
15. Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 1995; 13: 477.
16. Foutanini G, Lucchi M, Viguati S, et al. Angiogenesis as a prognostic indicator of survival in non-small cell lung carcinoma: a prospective study. J Natl Cancer Inst 1997; 89: 881.
17. Vacca A, Ribatti D, Roucalli L, et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994; 87: 503-8.
18. Vacca A, Di Loreto M, Ribatti D, et al. Bone marrow of patients with active Multiple Myeloma angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1 and CD44. Am J Hematol 1995; 50: 9-14.
19. Ribatti D, Vacca A, Nico B, et al. Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and structural study. Eur J Haematol 1996; 56: 45-53.
20. Rajkumar V, Leong I, Roche P, et al. Prognostic value of bone marrow angiogenesis on multiple myeloma. Clin Cancer Res 2000; (6): 3111-6.
21. Kini AR, Kay NE, Peterson LA. Increased bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia 2000; 14: 1414-8.
22. Kay N, Jelinek D, Peterson LA. Angiogenesis in B-chronic lymphocytic leukemia. Leukemia Res 2001; 25: 485-6.
23. Vacca A, Ribatti D, Presta M, et al. Bone marrow neovasculatization, plasma cell angiogenic potential and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 1999; 93: 3064-73.
24. Perez-Atayde AR, Sallan SE, Tedrow U, et al. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997; 150: 815-21.
25. Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000; 95: 309-13.
26. Mesa R, Hanson C, Rajkumar V, et al. Evaluation and clinical correlations of bone marrow angiogenis in myelofibrosis with myeloid metaplasia. Blood 2000; 96: 10.
27. De Bont E, Rosati S, Jacobs S, et al. Increased bone marrow vascularization in patients with acute myeloid leukemia - a possible role for vascular endothelial growth factor. Br J Haematol 2001; 113: 296-304.
28. Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000; 96: 2240-5.
29. Pruneri G, Bertolini F, Soligo D, et al. Angiogenesis in myelodysplastic syndromes. Br J Cancer 1999; 81:8 1398-1401.
30. Korkolopoulou P, Apostolidou E, Pavlopoulos P, et al. Prognostic evaluation of the microvascular network in myelodysplastic syndromes. Leukemia 2001; 15: 1369-76.
31. Clatch R, Krigman H, Peters M, et al. Dysplastic haemopoiesis following orthotopic liver transplantation: comparison with similar changes in HIV infection and primary myelodysplasia. Br J Haematol 1994; 88: 685-92.
32. Thiele J, Zirbes T, Wiemers P, et al. Incidence of apoptosis in HIV-myelopathy, myelodysplastic syndromes and non-specific inflammatory lesions of the bone marrow. Histopathology 1997; 30: 307-11.
33. Karcher D, Frost A. The bone marrow in human immunodeficiency virus (HIV)-related diseases. Morphology and clinical correlation. Am J Clin Pathol 1991; 95: 63-71.
34. Thiele J, Zirbes T, Bertsch HP, et al. AIDS-related bone marrow lesions - myelodysplastic features or predominant inflammatory reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling. Anal Cell Pathol 1996; 11: 141-57.
35. Katsarou O, Terpos E, Patsouris E, et al. Myelodysplastic features in patients with long-term HIV infection and hemophilia. Hemophilia 2001; 7: 47-52.
36. Centers for Disease Control, US Department of Health and Human Services Classification system for human T-lymphotropic virus infections. Ann Intern Med 1986; 105: 234-7.
37. Harris NL, Jaffe ES, Diebold J, et al. The Worm Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
38. Shi SR, Key ME, Kalra K. Antigen retrieval in formalin-fixed, paraffin embedded tissues, an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39: 741-8.
39. Hsu SM, Raine L, Fanger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-80.
40. Hansen S, Grabau DA, Rose C, et al. Angiogensis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Lab Invest 1998; 78: 1563-73.
41. Bruyn PPH, Breen PC, Thomas TB. The microcirculation of the bone marrow. Anat Rec 1970; 168: 55-68.
42. Branemark PI. Bone marrow microvascular structure and function. Adv Microcirc 1968; 1: 1-65.
43. Yamaguchi H, Ishii E, Saito S, et al. Umbilical vein endothelial cells are an important source of c-kit and stem cell factor which regulate the proliferation of haemopoietic progenitor cells. Br J Haematol 1996; 94: 606-11.
44. Fiedler W, Graeven U, Ergun S, et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 1997; 89: 1870-5.
45. Garcia-Monzon C, Sanchez-Madrid F, Garcia-Buey L, et al. Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology 1995; 108: 231-41.
46. Vermeulen P, Verhoeven D, Fierens H, et al. Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study. Br J Cancer 1995; 71: 340-3.
47. Bellamy W, Richter L, Frutiger Y, et al. Vascular endothelial cell growth factor (VEGF) is an autocrine promoter of ALIP and leukemia progenitor formation in myelodysplastic syndromes (MDS). Blood 1999; 94 (Suppl 1): 389α (Abstr).
48. Schneider D, Picker L. Myelodysplasia in the acquired immune deficiency syndrome. Am J Clin Pathol 1985; 84: 144-52.
49. Spivak J, Bender B, Quinn T. Hematologic abnormalities in the acquired immune deficiency syndrome. Am J Med 1984; 77: 224-8.
50. Scadden D, Zeira M, Woon A, et al. Human immunodeficiency virus infection of human bone marrow stromal fibroblasts. Blood 1990; 76 (2): 317-22.
51. Moses A, Williams S, Heneveld M, et al. Human immunodeficiency virus infection of bone marrow endothelial reduces induction of stromal hematopoietic growth factors. Blood 1996; 87 (3): 919-25.
52. + hematopoietic progenitors express low levels of CD34, the high affinity receptor for human immunodeficiency virus type 1. Blood 1995; 84 (6): 1896-905.
53. Chi D, Henry J, Kelly J, et al. The effects of HIV infection on endothelial function. Endothelium 2000; 7 (4): 223-42.
54. Hymes K, Karpatkin S. Human immunodeficiency virus infection and thrombotic microangiopathy. Semin Hematol 1997; 34 (2): 117-25.
55. Collins T, Read M, Neish A, et al. Transcriptional regulation of endothelial cell adhesion molecules: NF-Kappa B and cytokine-inducible enhancers. FASEB J 1995; 9: 899-909.